Atherton Lane Advisers’s Gilead Sciences GILD Stock Holding History

Atherton Lane Advisers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$395K	Buy	3,900 +79	+2%	+$8.22K	0.02%	153
2015 Q3	$375K	Buy	3,821 +753	+25%	+$83.6K	0.02%	155
2015 Q2	$359K	Sell	3,068 -4,285	-58%	-$468K	0.02%	164
2015 Q1	$722K	Sell	7,353 -600	-8%	-$60.9K	0.04%	143
2014 Q4	$750K	Buy	7,953 +118	+2%	+$12.2K	0.04%	147
2014 Q3	$834K	Sell	7,835 -279	-3%	-$27.3K	0.05%	143
2014 Q2	$673K	Sell	8,114 -125	-2%	-$9.73K	0.04%	160
2014 Q1	$584K	Hold	8,239	–	–	0.04%	97
2013 Q4	$619K	Buy	8,239 +72	+0.9%	+$5.01K	0.04%	95
2013 Q3	$513K	Buy	8,167 +117	+1%	+$6.99K	0.04%	90
2013 Q2	$413K	Buy	+8,050	New	+$420K	0.03%	98

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Atherton Lane Advisers's GILD Position: Q4 2015 in Review

Atherton Lane Advisers increased its Gilead Sciences (GILD) stake by 2.1% in Q4 2015, buying an estimated $8.22K and bringing the position to 3,900 shares worth $395K. The position accounts for 0.02% of the portfolio, ranked #153.

Atherton Lane Advisers first reported a position in GILD in Q2 2013 and has held it in 11 quarters since. The position peaked at $834K in Q3 2014. 1,627 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

Atherton Lane Advisers held 3,900 shares of Gilead Sciences worth $395K as of Q4 2015.
Atherton Lane Advisers bought 79 Gilead Sciences shares in Q4 2015, an estimated $8.22K.
Gilead Sciences made up 0.02% of Atherton Lane Advisers's portfolio in Q4 2015, its #153 holding.
Atherton Lane Advisers first reported a position in Gilead Sciences in Q2 2013 and has held it in 11 quarters since.
Atherton Lane Advisers's Gilead Sciences position peaked at $834K in Q3 2014.
1,627 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Atherton Lane Advisers's 13F filing for Q4 2015, filed 16 Feb 2016.